This Article Full Text Full Text (PDF) All Versions of this Article: 2002-0191OCv1 28/6/738    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weiner, D. J. Articles by Janmey, P. A. Search for Related Content PubMed PubMed Citation Articles by Weiner, D. J. Articles by Janmey, P. A.

The Antimicrobial Activity of the Cathelicidin LL37 Is Inhibited by F-actin Bundles and Restored by Gelsolin

Division of Pulmonary Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and Department of Physiology, University of Pennsylvania, Institute for Medicine and Engineering, Philadelphia, Pennsylvania

Address correspondence to: Paul A. Janmey, Dept. of Physiology, University of Pennsylvania, Institute for Medicine and Engineering, 1010 Vagelos Research Laboratories, 3340 Smith Walk, Philadelphia, PA 19104. E-mail: janmey{at}mail.med.upenn.edu

Antimicrobial peptides are part of the innate host defense system, and inactivation of these peptides is implicated in airway infections in cystic fibrosis (CF). The sputum of patients with CF contains anionic polyelectrolytes, including F-actin and DNA not found in normal airway fluid. These anionic filaments aggregate to contribute to the altered viscoelastic properties of CF sputum. We hypothesized that the airway components stabilizing bundles of F-actin and DNA are in part cationic antimicrobial agents, and that appropriate modification of diseased airway fluid of patients with CF might dissociate these bundles and restore antimicrobial activity. We demonstrate that the human cathelicidin peptide LL37 forms bundles with F-actin and DNA, which are dissolved by gelsolin and DNase, respectively. Coincident with bundle formation, antimicrobial activity of LL37 is inhibited by F-actin and DNA. Pseudomonas bacteria were killed by low concentrations of LL37, but killing was significantly reduced in the presence of F-actin. The actin filament–fragmenting protein gelsolin restored bactericidal activity nearly completely. In a growth inhibition assay, the effects of F-actin were confirmed, and DNA was also shown to inhibit the activity of LL37. When added to CF sputum, gelsolin significantly reduced the growth of bacteria, suggesting activation of endogenous antimicrobial factors. These findings may have therapeutic implications for treatments previously thought to alter only the viscoelastic properties of airway secretions and amplify the possible advantage of gelsolin in CF treatment.

Abbreviations: cystic fibrosis, CF • CF transmembrane conductance regulator, CFTR • dynamic light scattering, DLS • interleukin, IL • room temperature, RT

This article has been cited by other articles:

				R. Bucki, D. B. Namiot, Z. Namiot, P. B. Savage, and P. A. Janmey Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13 J. Antimicrob. Chemother., August 1, 2008; 62(2): 329 - 335. [Abstract] [Full Text] [PDF]

				V. J. Broughton-Head, J. Shur, M. P. Carroll, J. R. Smith, and J. K. Shute Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1240 - L1249. [Abstract] [Full Text] [PDF]

				L. K. Sanders, W. Xian, C. Guaqueta, M. J. Strohman, C. R. Vrasich, E. Luijten, and G. C. L. Wong Control of electrostatic interactions between F-actin and genetically modified lysozyme in aqueous media PNAS, October 9, 2007; 104(41): 15994 - 15999. [Abstract] [Full Text] [PDF]

				R. Bucki, A. G. Sostarecz, F. J. Byfield, P. B. Savage, and P. A. Janmey Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum J. Antimicrob. Chemother., September 1, 2007; 60(3): 535 - 545. [Abstract] [Full Text] [PDF]

				P. S. Hiemstra Antimicrobial peptides in the real world: implications for cystic fibrosis Eur. Respir. J., April 1, 2007; 29(4): 617 - 618. [Full Text] [PDF]

				R. Bucki, F. J. Byfield, and P. A. Janmey Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum Eur. Respir. J., April 1, 2007; 29(4): 624 - 632. [Abstract] [Full Text] [PDF]

				M. J. DiNubile Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin" Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1240 - C1242. [Full Text] [PDF]

				C. Guaqueta, L. K. Sanders, G. C. L. Wong, and E. Luijten The Effect of Salt on Self-Assembled Actin-Lysozyme Complexes Biophys. J., June 15, 2006; 90(12): 4630 - 4638. [Abstract] [Full Text] [PDF]

				Y. E. Lau, D. M. E. Bowdish, C. Cosseau, R. E. W. Hancock, and D. J. Davidson Apoptosis of Airway Epithelial Cells: Human Serum Sensitive Induction by the Cathelicidin LL-37 Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 399 - 409. [Abstract] [Full Text] [PDF]

				G. Candiano, M. Bruschi, N. Pedemonte, E. Caci, S. Liberatori, L. Bini, C. Pellegrini, M. Vigano, B. J. O'Connor, T. H. Lee, et al. Gelsolin Secretion in Interleukin-4-treated Bronchial Epithelia and in Asthmatic Airways Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1090 - 1096. [Abstract] [Full Text] [PDF]

				J. X. Tang, Q. Wen, A. Bennett, B. Kim, C. A. Sheils, R. Bucki, and P. A. Janmey Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L599 - L605. [Abstract] [Full Text] [PDF]

				R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF]